Test Price
2,800 AED✅ Home Collection Available
MED25 Gene CMT2B2 Next-Generation Sequencing DNA Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Core Metrics
- ✔ 99.9% Diagnostic Sensitivity – ISO‑accredited NGS processing (Illumina platform)
- ✔ VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Daily 8 AM–11 PM)
- ✔ Post‑test Telephonic Clinical Guidance & Pre‑test Genetic Counselling Included
- ✔ Direct Insurance Billing Verification via WhatsApp +971 54 548 8731
- ✔ DHA Licensed Facility #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City
Test Overview & Methodology
This advanced genetic test sequences the entire coding region of the MED25 gene to diagnose Charcot‑Marie‑Tooth disease type 2B2 (CMT2B2)—a progressive hereditary neuropathy—using next‑generation sequencing (NGS) on the Illumina platform with 99.9% diagnostic sensitivity. The test is performed on a peripheral whole blood sample collected via VIP mobile phlebotomy under strict temperature‑controlled cold‑chain logistics. Results are delivered within 3 to 4 weeks and include a post‑result telephonic consultation with a DHA‑licensed genetics specialist.
| Feature | Our MED25 NGS Test | Closest UAE Alternative |
|---|---|---|
| Precision | 99.9% sensitivity, full gene coverage | Limited panel, ~85% sensitivity |
| Methodology | NGS (Illumina platform, full coding region) | Sanger sequencing or older NGS |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Price | 2,800 AED (all‑inclusive) | 3,500+ AED (often additional fees) |
| Sample Collection | VIP Mobile Phlebotomy (8 AM–11 PM) with cold‑chain logistics | Clinic visit only |
| Insurance Billing | Direct WhatsApp verification +971 54 548 8731 | Manual claims process |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Genetics (DHA Registration ID: 9294403), I emphasize that this MED25 genetic test identifies inherited risk for CMT2B2; however, a definitive diagnosis requires correlation with a comprehensive clinical neurological examination and detailed family history. Pre‑ and post‑test genetic counselling is essential to accurately interpret findings and understand implications for family members. The test should always be performed under the supervision of a qualified genetics specialist.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics
Medication Advisory
Important Safety Notice
Do not discontinue any prescribed medication without consulting your treating physician. This test is intended for genetic risk assessment and does not replace ongoing neurological care or acute medical management. Always follow the clinical advice of your primary healthcare provider.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide informed consent; current anticoagulant therapy without physician clearance for blood draw; known severe needle phobia with no medical alternative.
- Emergency Red Flags – Seek immediate medical attention if you experience: Sudden paralysis, respiratory distress, severe unrelenting pain, or rapid progression of muscle weakness. This genetic test is not an acute diagnostic tool.
- Minor Patients: For individuals under 18 years, a parent or legal guardian must accompany the child and provide written consent; a mandatory pre‑test genetic counselling session applies.
Patient FAQ & Clinical Guidance
1. What is the MED25 gene CMT2B2 genetic test used for?
This test sequences the MED25 gene to diagnose Charcot‑Marie‑Tooth disease type 2B2, a hereditary neuropathy causing progressive muscle weakness and sensory loss. It is intended for individuals with clinical suspicion of CMT2B2, a family history of the condition, or carriers seeking reproductive planning. The result guides neurologists and genetic counsellors in tailoring surveillance and management.
2. How is the test performed and what sample is required?
A peripheral whole blood sample is collected by our DHA‑licensed phlebotomist at your home via VIP mobile phlebotomy using temperature‑controlled cold‑chain logistics. The sample is then processed on the Illumina NGS platform in our ISO‑certified laboratory. A pre‑test genetic counselling session is conducted to document clinical history and draw a pedigree chart.
3. What is the turnaround time and cost in UAE, and is insurance accepted?
The test costs 2,800 AED with results delivered within 3 to 4 weeks, including a telephonic post‑consultation to explain the findings. We provide direct billing assistance; simply send your insurance card via WhatsApp to +971 54 548 8731 to verify coverage instantly. Your genetic data is stored and shared only with your explicit consent in full compliance with UAE PDPL.
4. Who should consider taking this genetic test?
Individuals with unexplained progressive peripheral neuropathy, a known family history of CMT, or those with clinical features suggestive of axonal neuropathy. The test is also recommended for adults planning a family who are known carriers of MED25 mutations. A neurologist or genetic counsellor can help determine if this test is appropriate for your clinical situation.
5. Will the test results affect my current treatment plan?
Test results may guide your neurologist in optimizing your management plan, but they should never be used to discontinue or alter any prescribed medication without direct consultation with your treating physician. The genetic finding provides important prognostic information and can help tailor surveillance strategies for associated complications.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This diagnostic service operates under DHA Facility License No. 1143. All genetic testing procedures are conducted in accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Data Security Commitment: All genetic data is encrypted and stored on UAE‑based servers. Your results are shared only with you and your designated healthcare provider upon explicit written consent. We adhere to strict data minimization and purpose limitation principles.
Clinical & Logistical Metadata
| Test Name | MED25 Gene Charcot‑Marie‑Tooth Disease Type 2B2 (CMT2B2) Next‑Generation Sequencing DNA Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube); Dried Blood Spot (FTA card) also accepted |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina platform, full coding region analysis |
| ICD‑10‑CM Code | G60.0 |
| LOINC Code | 96646-0 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians